3P BIOTECH NORWAY AS: årsregnskap 2021 vs 2020
Shrank 24% on revenue, slipped into loss
approved 2022-06-24; registry 2022-07-12; journal 2022 686518
Summary
What changed
Comparing Årsregnskap 2021 with 2020 for 3P BIOTECH NORWAY AS. Revenue 96.4k NOK → 73.4k NOK (-23.9%). Net result +3 624 NOK → -53.6k NOK. Equity 396.9k NOK → 343.3k NOK.
On the constructive side: cash rose; current ratio back above 1×. Pressures included: revenue fell; operating result weakened; fell into a net loss.
Also worth watching: book investments changed. All figures are taken from the published annual accounts for 3P BIOTECH NORWAY AS.
At a glance
Scorecard
What improved
-
↑
Cash rose
Bank deposits 1 691 NOK → 34.9k NOK (+1962.5% YoY). Calculated
-
↑
Current ratio back above 1×
Current ratio 0.96× → 1.22×. Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 96.4k NOK to 73.4k NOK (-23.9% YoY). Calculated
-
↓
Operating result weakened
Operating result +34.3k NOK → -6 253 NOK (op. margin 35.6% → -8.5%). Calculated
-
↓
Fell into a net loss
Net result flipped from 3 624 NOK profit to a loss of 53.6k NOK. Calculated
-
↓
Equity eroded
Book equity 396.9k NOK → 343.3k NOK. Calculated
Things to notice
-
·
Book investments changed
Investment / intangible book value 70.8k NOK → 91.3k NOK. Reported fact